Exogenous hormone administration and kidney health outcomes in females treated with in-vitro fertilization

接受体外受精治疗的女性的外源激素施用和肾脏健康结果

• 批准号: 486339
• 负责人: Kharbanda Sakshi
• 金额: $ 1.27万
• 依托单位: University of Calgary
• 依托单位国家: 加拿大
• 项目类别: Studentship Programs
• 财政年份: 2022
• 资助国家: 加拿大
• 起止时间: 2022-12-01 至 2023-12-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=486339&lang=en
• 关键词: Glomerular Filtration (Gfr); In-Vitro Fertilization (Ivf); Infertility; Kidney Function; Ovarian Stimulation

In-vitro fertilization (IVF), a form of fertility treatment, is presently responsible for ~2% of live births in Canada. IVF involves administration of high doses of sex hormones and results in increased egg production in the ovaries. Although we know that

体外受精(IVF)是一种生育治疗方式，目前在加拿大约占活产婴儿的2%。试管受精涉及到高剂量的性激素，并导致卵巢中卵子产量的增加。尽管我们知道